In ₹ Crore except Per Share Latest Annual	INDIACEM FY26	ULTRACEMCO FY26	RAMCOCEM FY26	DALBHARAT FY26	Peer Average
Valuation — at last close
P/E	—	40.25×	24.69×	◆ 23.18×	29.37×
P/B	◆ 0.92×	4.30×	2.13×	1.49×	2.64× -65%
EV/EBITDA	26.60×	20.63×	14.53×	◆ 9.18×	14.78× +80%
Market Cap	₹9,305 Cr	₹3.29L Cr	₹17,243 Cr	₹26,750 Cr	₹1.24L Cr -93%
Growth
Revenue CAGR 3Y	-7.18%	◆ 11.86%	3.44%	3.02%	6.11% -218%
Revenue CAGR 5Y	-0.11%	◆ 14.63%	11.28%	7.07%	10.99% -101%
Net Income CAGR 3Y	—	17.30%	◆ 30.45%	2.35%	16.70%
Revenue YoY (latest Q)	2.24%	◆ 18.81%	9.60%	4.27%	10.89% -79%
Net Income YoY (latest Q)	◆ 340.64%	21.28%	-63.06%	-185.77%	-75.85% +549%
Profitability
EBITDA Margin	8.84%	19.23%	15.90%	◆ 20.83%	18.65% -53%
Net Income Margin	-1.50%	◆ 9.25%	7.74%	7.82%	8.27% -118%
Return on Common Equity	-0.66%	◆ 11.08%	8.99%	6.44%	8.84% -107%
Return on Capital Employed	0.80%	◆ 11.85%	5.74%	6.59%	8.06% -90%
Return on Assets	-0.49%	◆ 5.95%	4.24%	3.64%	4.61% -111%
Credit & Quality
Total Debt/Equity	◆ 0.13×	0.28×	0.48×	0.37×	0.38× -65%
Interest Coverage	0.98×	◆ 6.61×	1.66×	3.61×	3.96× -75%
Scale — latest FY
Revenue / Total Income	₹4,485 Cr	₹88,512 Cr	₹9,029 Cr	₹14,804 Cr	₹37,448 Cr -88%
Net Income	−₹67.3 Cr	₹8,188 Cr	₹699 Cr	₹1,157 Cr	₹3,348 Cr -102%
Total Assets	₹13,403 Cr	₹1.41L Cr	₹16,636 Cr	₹33,312 Cr	₹63,775 Cr -79%
EPS	₹-2.17	₹277.62	₹29.56	₹60.73	₹122.64 -102%
Book Value per Share	₹326.69	₹2,600.23	₹342.51	₹946.26	₹1,296.33 -75%

◆ best value in the comp set per metric · Δ = subject vs average of the other companies.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.